Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells.
BACKGROUND
Activation of the enzyme telomerase, which has been associated with cellular immortality, may constitute a key step in the development of human cancer. Telomerase is repressed in most normal human somatic cells. This study was conducted, using a genetic complementation approach, with the aim of identifying and mapping the genes responsible for repressing telomerase and, simultaneously, to establish the effect of experimentally induced telomerase repression on human tumor cell growth.


METHODS
Individual human chromosomes isolated from normal diploid cells and tagged with bacterial antibiotic resistance genes (for later selection) were introduced into cells of the human breast carcinoma cell line 21NT by means of microcell transfer. Selected hybrid clones were screened for telomerase activity by use of the polymerase chain reaction-based telomere repeat amplification protocol (TRAP) assay, and the proliferative fate of the hybrid clones was determined. Regions of the introduced chromosomes associated with telomerase repression were mapped using segregant hybrids and a deletion analysis that employed microsatellite DNA markers.


RESULTS
Strong repression of telomerase was observed following transfer of human chromosome 3 into 21NT cells but not after transfer of chromosomes 8, 12, or 20. The vast majority of hybrid clones with repressed telomerase entered permanent growth arrest after 10-18 population doublings. Deletion analysis of nonrepressed segregant monochromosome 3 hybrids indicated two regions on the short arm of chromosome 3 (3p21.3-p22 and 3p12-21.1) where telomerase regulator genes may be located.


CONCLUSIONS
Telomerase in human breast cancer cells is efficiently repressed by a gene or genes on normal human chromosome 3p, and this repression is associated with permanent growth arrest of the tumor cells.
Cuthbert
A P
AP
Department of Biology and Biochemistry, Brunel University, Uxbridge, UK.
Bond
J
J
Trott
D A
DA
Gill
S
S
Broni
J
J
Marriott
A
A
Khoudoli
G
G
Parkinson
E K
EK
Cooper
C S
CS
Newbold
R F
RF
D000328:Adult; D001943:Breast Neoplasms / Q000473:pathology*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000201:enzymology / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D002459:Cell Fusion; D002875:Chromosomes / Q000378:metabolism / Q000648:ultrastructure; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D018014:Gene Transfer Techniques; D006131:Growth Inhibitors / Q000235:genetics* / Q000502:physiology; D006801:Humans; D006822:Hybrid Cells; D017404:In Situ Hybridization, Fluorescence; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D016133:Polymerase Chain Reaction; D012097:Repressor Proteins / Q000235:genetics* / Q000502:physiology; D019098:Telomerase / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D016615:Telomere / Q000378:metabolism; D014407:Tumor Cells, Cultured
D006131:Growth Inhibitors; D009363:Neoplasm Proteins; D012097:Repressor Proteins; D019098:Telomerase